Sign in
4

Changes in Ownership

SAB Biotherapeutics, Inc. Filed Acc 0001493152-21-026380

Options or other derivatives

  • Chief Compliance Officer acquired 128,202 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Pommer Jerry Lynn · Chief Compliance Officer

Table II: Derivative

4 lines
Date Transaction Shares Owned after D/I
2021-10-22 Grant or award : show line 1 in the form Employee Stock Option (right to buy) +69,793 69,793 D
2021-10-22 Grant or award : show line 2 in the form Employee Stock Option (right to buy) +14,540 14,540 D
2021-10-22 Grant or award : show line 3 in the form Employee Stock Option (right to buy) +6,979 6,979 D
2021-10-22 Grant or award : show line 4 in the form Earnout Rights (Restricted Stock Units) +36,890 36,890 D
Loading xslF345X03/ownership.xml…